RDEA#

Related by string. * * MEK inhibitor RDEA# . RDEA# RDEA# RDEA# RDEA# . mg RDEA# . HIV RDEA# . RDEA# potent . evaluating RDEA# *

Related by context. Frequent words. (Click for all words.) 67 Phase 1b 67 Phase Ib 66 preclinical studies 65 INCB# [002] 65 Phase 2a 65 Phase 2a clinical 65 perifosine 64 pharmacokinetic profile 64 PRX # 64 Phase 2b clinical 64 XL# [003] 64 ANA# 63 investigational drug 63 pharmacodynamic 63 IMGN# 63 antiviral activity 63 investigational compound 63 ADX# 63 CK # 63 Phase IIa 63 MDV# 63 RG# [001] 63 AEZS 62 CYT# 62 tolerability profile 62 Phase III clinical 62 pivotal Phase III 62 pharmacokinetic 62 tolerability 62 Phase IIa clinical 62 carfilzomib 61 hematological malignancies 61 preclinical 61 antitumor activity 61 PMX # 61 Locteron 61 orally administered 61 picoplatin 61 oral dosing 61 Phase 2b 61 dose escalation study 61 MGCD# [002] 61 Phase IIb 60 laquinimod 60 NKTR 60 Phase IIb clinical 60 TMC# [001] 59 immunogenicity 59 Phase IIb trial 59 Phase III clinical trials 59 pivotal Phase 59 ENMD 59 Phase 2b study 59 CUDC 59 bavituximab 59 ARRY 58 AEOL # 58 dosing regimens 58 protease inhibitor 58 hormone refractory prostate cancer 58 APD# 58 elesclomol 58 Preclinical studies 58 T DM1 58 tivozanib 58 mipomersen 58 AZD# 57 humanized monoclonal antibody 57 pharmacokinetics 57 arimoclomol 57 randomized Phase 57 bortezomib 57 immunotherapeutic 57 ITMN 57 gemcitabine 57 MB# [004] 57 pharmacodynamics 57 diabetic nephropathy 57 PBT2 57 relapsing remitting multiple sclerosis 56 taxane 56 taxanes 56 FOLOTYN 56 Riquent 56 disease modifying 56 docetaxel 56 Albuferon 56 immunosuppressive 56 hematologic malignancies 56 prodrug 56 satraplatin 56 chronic hepatitis C. 56 immunogenic 56 BiovaxID 56 preclinical models 56 anticancer 56 GM CSF 56 initiate Phase 55 PLX# 55 Phase III 55 anti angiogenic

Back to home page